Celldex Therapeutics’ $287.5 Million Common Stock Offering

Lowenstein Sandler represented Celldex Therapeutics in the offering.Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) executed its $287.5 million public offering of common stock. Jefferies, SVB Leerink, Guggenheim…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now